| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.19M | 2.04M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 32.94M | 1.29M | -5.54M | -2.60M | -1.66M | 0.00 |
| EBITDA | -207.46M | -100.94M | -72.62M | -76.98M | -30.34M | -12.20M |
| Net Income | -222.94M | -100.19M | -53.40M | -50.99M | -31.25M | -13.89M |
Balance Sheet | ||||||
| Total Assets | 288.77M | 329.79M | 406.81M | 440.44M | 193.35M | 24.59M |
| Cash, Cash Equivalents and Short-Term Investments | 214.01M | 262.54M | 332.45M | 390.08M | 160.50M | 14.73M |
| Total Debt | 8.46M | 10.56M | 13.72M | 12.06M | 1.15M | 840.00K |
| Total Liabilities | 60.57M | 51.48M | 47.86M | 48.90M | 281.68M | 86.66M |
| Stockholders Equity | 228.20M | 278.31M | 358.95M | 391.54M | -88.32M | -62.07M |
Cash Flow | ||||||
| Free Cash Flow | -156.00M | -78.29M | -72.17M | -61.15M | -38.97M | -11.99M |
| Operating Cash Flow | -150.32M | -66.09M | -56.41M | -46.50M | -29.99M | -11.01M |
| Investing Cash Flow | 136.60M | 108.19M | 32.72M | -296.01M | 3.31M | -13.27M |
| Financing Cash Flow | -6.10M | 1.01M | 3.27M | 289.93M | 184.76M | 840.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | $1.77B | -9.64 | -68.95% | ― | 45.98% | 44.14% | |
55 Neutral | $95.07M | -0.94 | -75.54% | ― | -19.11% | 73.51% | |
54 Neutral | $810.46M | -7.85 | -33.69% | ― | ― | -15.43% | |
51 Neutral | $1.11B | -10.50 | -23.63% | ― | 25.24% | -12.96% | |
50 Neutral | $1.24B | -3.72 | -192.35% | ― | 89.90% | 5.13% | |
48 Neutral | $6.49B | -12.80 | -38.65% | ― | ― | 15.04% |
On January 16, 2026, SES AI Corporation is scheduled to present at the Needham Growth Conference, highlighting its strategy to accelerate the energy transition by integrating AI-driven battery materials discovery and health management into its product offerings. The company reports $16.4 million in revenue for the first three quarters of 2025, maintains full-year 2025 revenue guidance of $20 million to $25 million, and cites a strong liquidity position of $214 million as of September 30, 2025, while emphasizing that its Molecular Universe platform underpins competitive advantages in ESS, cells and electrolyte materials, and is expected to support revenue growth and value creation from 2026 onward.
The most recent analyst rating on (SES) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on SES AI Corporation Class A stock, see the SES Stock Forecast page.
On November 6, 2025, Dr. Jang Wook Choi announced his resignation from the Board of Directors of SES AI Corporation, effective November 10, 2025, citing personal reasons. His departure is not due to any disagreements with the company’s management or operations, indicating stability in the company’s leadership and strategic direction.
The most recent analyst rating on (SES) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on SES AI Corporation Class A stock, see the SES Stock Forecast page.